SCIENCE IN SPORT PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.5 GBX | 0.00% |
|
-1.33% | +57.45% |
| Jun. 28 | EARNINGS AND TRADING: Thruvision loss widens but Polarean loss narrows | AN |
| Jun. 28 | Science in Sport Appoints New Finance, Commercial Chiefs | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company is in debt and has limited leeway for investment
- The company is highly valued given the cash flows generated by its activity.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Food Processing
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +57.45% | 42.27M | - | ||
| +14.92% | 8.36B | D+ | ||
| +3.08% | 7.69B | C- | ||
| -24.04% | 4.6B | - | ||
| -9.42% | 3.58B | B- | ||
| -19.73% | 3.22B | D | ||
| -8.57% | 1.28B | - | - | |
| -25.56% | 1.11B | B+ | ||
| -9.27% | 887M | C+ | ||
| -16.10% | 856M | C+ |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
-
Finances
Valuation
P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- SIS Stock
- Ratings Science in Sport plc
